These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9475257

  • 1. Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure.
    Nakamura Y, Ryoke T, Tanaka N, Ohkusa T, Matsuzaki M.
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):171-8. PubMed ID: 9475257
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic effects of celiprolol in patients with ischemic and non-ischemic cardiomyopathy.
    Hennersdorf MG, Perings C, Vester EG.
    Int J Cardiol; 1999 Mar 15; 68(3):289-95. PubMed ID: 10213280
    [Abstract] [Full Text] [Related]

  • 3. Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7.1 cardiomyopathic hamster.
    Villame J, Massicotte J, Jasmin G, Dumont L.
    Cardiovasc Drugs Ther; 2001 Jan 15; 15(1):41-8. PubMed ID: 11504162
    [Abstract] [Full Text] [Related]

  • 4. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, Kitamura S, Tomoike H, Hori M, Kitakaze M.
    Circulation; 2004 Aug 10; 110(6):692-9. PubMed ID: 15262839
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Experimental rat model representing both acute and chronic heart failure related to autoimmune myocarditis.
    Koyama S, Kodama M, Izumi T, Shibata A.
    Cardiovasc Drugs Ther; 1995 Oct 10; 9(5):701-7. PubMed ID: 8573553
    [Abstract] [Full Text] [Related]

  • 8. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
    Jakubetz J, Schmuck S, Poller U, Fuchs B, Gorf A, Radke J, Pönicke K, Brodde OE.
    J Cardiovasc Pharmacol; 1999 Mar 10; 33(3):461-72. PubMed ID: 10069683
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker.
    Sanderson JE, Chan WW, Hung YT, Chan SK, Shum IO, Raymond K, Woo KS.
    Br Heart J; 1995 Nov 10; 74(5):502-7. PubMed ID: 8562234
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Positive inotropic effects due to partial agonistic activity of the beta-adrenoceptor antagonist celiprolol following amplification of cAMP formation in failing human myocardium.
    Böhm M, Schulz C, Schwinger RH, Erdmann E.
    J Cardiovasc Pharmacol; 1992 Sep 10; 20(3):479-89. PubMed ID: 1279296
    [Abstract] [Full Text] [Related]

  • 13. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B, Guy S, Riddell JG.
    J Cardiovasc Pharmacol; 1997 Dec 10; 30(6):817-23. PubMed ID: 9436823
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L.
    J Am Coll Cardiol; 2002 Oct 02; 40(7):1248-58. PubMed ID: 12383572
    [Abstract] [Full Text] [Related]

  • 17. Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group.
    Witchitz S, Cohen-Solal A, Dartois N, Weisslinger N, Juste K, Darmon JY.
    Am J Cardiol; 2000 Jun 15; 85(12):1467-71. PubMed ID: 10856394
    [Abstract] [Full Text] [Related]

  • 18. Role of increased alpha 1-adrenergic activity in cardiomyopathic Syrian hamster.
    Kagiya T, Hori M, Iwakura K, Iwai K, Watanabe Y, Uchida S, Yoshida H, Kitabatake A, Inoue M, Kamada T.
    Am J Physiol; 1991 Jan 15; 260(1 Pt 2):H80-8. PubMed ID: 1671540
    [Abstract] [Full Text] [Related]

  • 19. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
    Mulumba M, Céméus C, Dumont L, du Souich P, Ong H, Marleau S.
    Growth Horm IGF Res; 2007 Apr 15; 17(2):96-103. PubMed ID: 17280860
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.